ARO次世代医療センター

Medicine & Life Sciences

1. Japan 100%
2. Non-Small Cell Lung Carcinoma 90%
3. Surgeons 73%
4. Safety 59%
5. Clinical Trials 56%
6. pitavastatin 51%
7. negamycin 50%
8. ICG 001 44%
9. Heart Failure 44%
10. Therapeutics 43%
11. Angiotensin Receptor Antagonists 42%
12. Catenins 41%
13. Type 2 Diabetes Mellitus 41%
14. Nonsense Codon 41%
15. 130-nm albumin-bound paclitaxel 39%
16. osimertinib 39%
17. Confidence Intervals 38%
18. Surgical Instruments 37%
19. Survival 36%
20. Pediatrics 36%
21. Blood Pressure 36%
22. Mutation 35%
23. Neoplasms 34%
24. Hydroxymethylglutaryl-CoA Reductase Inhibitors 33%
25. Amlodipine 33%
26. Lipids 32%
27. Research Personnel 32%
28. Sutures 32%
29. Carboplatin 31%
30. Drug Therapy 31%
31. ErbB Receptors 31%
32. Colorectal Neoplasms 31%
33. Clinical Trials, Phase I 30%
34. Progression-Free Survival 30%
35. Inbred mdx Mouse 30%
36. Peroxidases 29%
37. Nanoparticles 29%
38. Bevacizumab 28%
39. Rosuvastatin Calcium 28%
40. HLA-A*24:02 antigen 26%
41. Dilated Cardiomyopathy 26%
42. Laparoscopy 25%
43. Dystrophin 25%
44. Registries 25%
45. Gentamicins 25%
46. Natural Orifice Endoscopic Surgery 24%
47. Galectin 1 23%
48. Pemetrexed 23%
49. Protein-Tyrosine Kinases 23%
50. 11-beta-Hydroxysteroid Dehydrogenases 23%
51. Arabidopsis 23%
52. Fingers 23%
53. Breath Holding 22%
54. Fundoplication 22%
55. Hepacivirus 22%
56. Carotid Intima-Media Thickness 22%
57. Gefitinib 21%
58. Parkinson Disease 21%
59. Vagus Nerve Stimulation 21%
60. Pharmaceutical Preparations 21%
61. Information Management 21%
62. Deep Brain Stimulation 21%
63. Skeletal Muscle 21%
64. Mucocutaneous Lymph Node Syndrome 20%
65. Subthalamic Nucleus 20%
66. Atherosclerosis 20%
67. Safety Management 20%
68. Augmented Reality 20%
69. Cancer Vaccines 19%
70. Cushing Syndrome 19%
71. Irinotecan 19%
72. Electric Impedance 18%
73. Machine Learning 18%
74. Equipment and Supplies 18%
75. Radiotherapy 18%
76. Stroke Volume 17%
77. Lung 17%
78. Chemoradiotherapy 17%
79. Fibrosis 17%
80. Angiotensin-Converting Enzyme Inhibitors 17%
81. limaprost 16%
82. Ligation 16%
83. remimazolam 16%
84. Obstructive Sleep Apnea 16%
85. Cadherins 16%
86. Endoscopy 16%
87. Dendritic Cells 16%
88. Post-Traumatic Stress Disorders 16%
89. terpinolene 15%
90. Pressure 15%
91. Exercise 15%
92. Hepatitis B virus 15%
93. K-115 15%
94. Multicenter Studies 15%
95. Area Under Curve 15%
96. hachimijiogan 15%
97. Cell- and Tissue-Based Therapy 15%
98. Cell-Free Nucleic Acids 15%
99. T-Lymphocytes 15%
100. Cyclophosphamide 15%